CFA Pharma SRL
The score of CFA Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +113 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CFA Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 24 Mar 2026
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 04 Jul 2022
CFA Pharma's financial analysis
- Solvency29.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CFA Pharma
CFA Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.715.650
- VAT number
- BE0428715650
- Peppol
- Registered · 0208:0428715650 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 1986
- Registered office
- 8902 Ypres
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
CFA Pharma (SRL) has been based in Ypres since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 6,743 € and equity of 153,937 €; its revenue is not published. Its solvency stands at 29.3%, below the median of its sector (44.2%).
Companies similar to CFA Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek DE Sweemer Retail sale of pharmaceutical products Ghent · balance sheet 525,307 €
- Ghekiere Retail sale of pharmaceutical products Zemst · balance sheet 525,361 €
- Smeets Farma Retail sale of pharmaceutical products Duffel · balance sheet 526,110 €
- Rudophar Retail sale of pharmaceutical products Oostkamp · balance sheet 526,499 €
- Apoteek Breckpot Retail sale of pharmaceutical products Aalst · balance sheet 523,391 €
- Pharmacie DU ROI Vainqueur Retail sale of pharmaceutical products Etterbeek · balance sheet 527,195 €
- LSRP Retail sale of pharmaceutical products Braives · balance sheet 527,233 €
- Wezel Pharma Retail sale of pharmaceutical products Mol · balance sheet 520,638 €
Frequently asked questions about CFA Pharma
What is the revenue of CFA Pharma?
CFA Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CFA Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0428715650 for CFA Pharma, if the company is VAT-registered. Its company number (CBE) is 0428.715.650.
Where is the registered office of CFA Pharma?
According to the CBE register, the registered office of CFA Pharma is in 8902 Ypres.
What is the equity of CFA Pharma?
At the close of the 2025 financial year, the equity of CFA Pharma amounts to 153,937 €, a solvency of 29.3% of total assets.
Who manages CFA Pharma?
The register lists 3 active mandates at CFA Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CFA Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →